Other Clinical Trial - Reversal of Heparin in Patients Undergoing

Status Terminated

Clinical Trial Summary

The study investigates the safety and efficacy of PMX-60056 for the Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)

Clinical Trial Description

PMX-60056 is being developed as a rapid and effective reversal agent for use in those situations where anticoagulation by heparin, or LMWH must be quickly stopped. Potential uses include reversal of anticoagulation induced to prevent clotting during surgical procedures, and rescue from cases of inadvertent or unexpected overdose. ;

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01312935
Study type	Interventional
Source	PolyMedix, Inc.
Contact
Status	Terminated
Phase	Phase 2
Start date	April 2011
Completion date	August 2012

View Details

See also
Status	Clinical Trial	Phase
Terminated	`NCT03959072` - Cardiac Cath Lab Staff Radiation Exposure
Not yet recruiting	`NCT05669222` - The FAVOR V AMI Trial	N/A
Recruiting	`NCT04566497` - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.	N/A
Recruiting	`NCT05240781` - Zotarolimus vs Sirolimus Eluting Stent in High Bleeding Risk	N/A
Recruiting	`NCT03378934` - Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention	Phase 4
Not yet recruiting	`NCT06025071` - Residual Inflammatory Risk-Guided colcHicine in Elderly Trial	Phase 4
Withdrawn	`NCT04043091` - Coronary Angiography in Critically Ill Patients With Type II Myocardial Infarction	N/A
Completed	`NCT02837744` - Studying Hemostatic Effect of Axiostat® Dressing on Radial Access After Percutaneous Procedure
Completed	`NCT03085823` - The All-comers Sirolimus-coated Balloon European Registry
Completed	`NCT02044146` - A Pharmacodynamic Study of a Personalized Strategy for P2Y12 Inhibition Versus Ticagrelor in Reducing Ischemic and Bleeding Risk	Phase 2/Phase 3
Completed	`NCT03131271` - Effect of Ice Bag Application to Femoral Region on Pain in Patients Undergoing Percutaneous Coronary Intervention	N/A
Completed	`NCT01156571` - A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)	Phase 3
Completed	`NCT01135667` - Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI	Phase 4
Unknown status	`NCT00751491` - Clopidogrel Versus Adenosin in Non Urgent Percutaneous Coronary Intervention (PCI)	Phase 3
Completed	`NCT00725868` - Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention	N/A
Completed	`NCT03708588` - Chewed Versus Integral Pill of Ticagrelor	Phase 4
Completed	`NCT04163393` - R-One Efficiency For PCI Evolution With Robotic Assistance	N/A
Recruiting	`NCT05554588` - Intrathrombus Thrombolysis Versus Aspiration Thrombectomy During Primary PCI	N/A
Recruiting	`NCT06080919` - Plaque Modification And Impact On Microcirculatory Territory After Drug-Coated Balloon Percutaneous Coronary Intervention (PLAMI).	N/A
Recruiting	`NCT05353140` - LAAO Versus NOAC in Patients With AF and PCI	N/A